DescriptionAdefovir Dipivoxil is an acyclic nucleotide analog prodrug of adefovir, functioning as a reverse transcriptase inhibitor—widely used in hepatitis B research. Each tablet delivers 10?mg of active compound. Manufactured by Chia?Tian Chongxin Pharmaceutical (Dinghe), approved under NMPA registration number H20080034, with drug code 86904127003695 and barcode 6937861350224.Ideal for in vitro or in vivo studies of antiviral mechanisms, viral drug resistance, and nucleoside analog pharmacodynamics. Not for clinical, diagnostic, or veterinary use—research use only. Contents hide 1 Adefovir Dipivoxil Tablets Product Specifications 2 Adefovir Dipivoxil Tablets Mechanism & Research Applications 3 Adefovir Dipivoxil Tablets Safety & Handling 4 Core Keywords 5 Research Use Disclaimer Adefovir Dipivoxil Tablets Product SpecificationsParameterDetailsProduct NameAdefovir Dipivoxil Tablets (Dinghe)Generic NameAdefovir DipivoxilCAS Number142340?99?6Molecular FormulaC??H??N?O?PMolecular Weight501.47?DaDosage FormFilm-coated tabletStrength10?mg per tabletQuantity14 tablets per boxApproval NumberChina NMPA H20080034Product Code86904127003695ManufacturerChongxin Pharmaceutical Co., Ltd.Barcode6937861350224Intended UseLaboratory research onlyStorageStore sealed at room temperature below 30?°CAdefovir Dipivoxil Tablets Mechanism & Research ApplicationsAdefovir Dipivoxil is a prodrug converted intracellularly to adefovir diphosphate, which inhibits hepatitis B virus polymerase by competing with natural deoxyadenosine triphosphate, causing DNA chain termination. It’s used extensively in research to study:HBV inhibition and viral replication kineticsDrug-resistance mutations and antiviral resilienceCombination therapies and HBV polymerase functionPharmacokinetic and pharmacodynamic profiling in preclinical modelsAdefovir Dipivoxil Tablets Safety & HandlingUse: Strictly for laboratory research; not for human or veterinary administrationStorage: Keep sealed and store below 30?°CHandling: Use PPE—lab coat, gloves, safety glassesDisposal: Follow institutional hazardous waste protocolsCore KeywordsAdefovir dipivoxil tablets, Dinghe antiviral tablet, 10?mg adefovir dipivoxil, HBV research compound, nucleotide analog for lab use, NMPA H20080034 adefovir, Chongxin adefovir dipivoxil, bulk antiviral research tablet, lab-grade reverse transcriptase inhibitor, hepatitis B prodrug researchResearch Use DisclaimerThis product is exclusively for laboratory research use and is not approved for clinical, therapeutic, diagnostic, or veterinary purposes. Improper use may pose health risks. Always adhere to institutional biosafety and local regulations.
